Concepts and targets in triple-negative breast cancer: recent results and clinical implications

Triple-negative breast cancer (TNBC) is a heterogeneous disease in which tumors are defined by lack of expression of the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) receptor. No targeted therapies are available for the treatment of...

ver descrição completa

Detalhes bibliográficos
Principais autores: Poornima Saha, Rita Nanda
Formato: Artigo
Idioma:English
Publicado em: SAGE Publishing 2016-09-01
coleção:Therapeutic Advances in Medical Oncology
Acesso em linha:https://doi.org/10.1177/1758834016657071